Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?

Mattia C. F. Prosperi, Sarah L. Ingham, Anthony Howell, Fiona Lalloo, Iain E. Buchan, Dafydd Gareth Evans. Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?. BMC Med. Inf. & Decision Making, 14:87, 2014. [doi]

@article{ProsperiIHLBE14,
  title = {Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?},
  author = {Mattia C. F. Prosperi and Sarah L. Ingham and Anthony Howell and Fiona Lalloo and Iain E. Buchan and Dafydd Gareth Evans},
  year = {2014},
  doi = {10.1186/1472-6947-14-87},
  url = {http://dx.doi.org/10.1186/1472-6947-14-87},
  researchr = {https://researchr.org/publication/ProsperiIHLBE14},
  cites = {0},
  citedby = {0},
  journal = {BMC Med. Inf. & Decision Making},
  volume = {14},
  pages = {87},
}